CASI Pharmaceuticals Inc

NASDAQ:CASI   11:07:27 AM EDT
0.35
-0.17 (-33.08%)
Earnings Announcements

Casi Pharmaceuticals Announces First Quarter 2022 Financial Results

Published: 05/12/2022 11:17 GMT
CASI Pharmaceuticals Inc (CASI) - Casi Pharmaceuticals Announces First Quarter 2022 Financial Results.
Q1 Revenue $9.0 Million.
Qtrly Loss per Share $0.06.
Revenue is expected to be $7.87 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $10.35 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.